chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had received the 1st dose 27Jul2021, second dose on 17Aug2021 and the 3rd dose on 20Aug2021; had received the 1st dose 27Jul2021, second dose on 17Aug2021 and the 3rd dose on 20Aug2021; Her heart did not feel well while at the site; This is a spontaneous report from a contactable pharmacist.   A 63-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration DOSE 3, 0.3 mL single on 20AUG2021 (at the age of 63 years) at single dose for COVID-19 immunisation. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown) DOSE 1, 0.3 mL, single administered intramuscularly on 27JUL2021 at single dose for COVID-19 immunisation. The patient previously took second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown) DOSE 2, 0.3 mL, single intramuscularly on 17Aug2021 at single dose for COVID-19 immunisation. The patient medical history was not reported. The patient concomitant medications were not reported. Patient had received the 1st dose 27Jul2021, second dose on 17Aug2021 and the 3rd dose on 20Aug2021 and Patient had initially said that her heart did not feel well while at the site, but now she is feeling fine and came back today and realized that she received a 3rd dose, initially she did not have her card, she had a picture of her Covid card, she had only the 1st dose that she had received from our location. What should we look for as far as reactions? We are going to report this VAERS if that helps you. At the time of reporting, the outcome of the events were unknown.   Information about lot/batch number has been requested.
Flushing and nausea Narrative: Pt was asked to remove hat and jacket. Monitored for additional 15minutes. Symptom resolved. Vital signs staable.
Per patients mother/guardian, mom thought it would be okay for the patient to receive the vaccination due to the fact that the patient was going to be 12 in September, and felt that the benefits outweighed the risks. Mother/Patient also attested that patient was 12 years of age/older
pt recv vax 12SEP95 & devel a fever between 103-104 8-9 days p/vax;3 other children given same lot# exp fevers;MD office indicated pt exp t102.4 x 24hr;fussiness & one loose stool on 20SEP95;no rash reported;pt seen by MD & recovered;
2 hours after first covid vaccine ears started to ring and 6 months later my ears are still ringing both ears.
Patient had received 3 required vaccines for school and stated they were ok and comfortable. Patient was sitting in chair for about 5 minutes when they stood up, took a step, and the passed out falling to the ground. Patient regained consciousness after only a few seconds. Vitals signs were taken and were WNL. Juice was given to the patient.  An assessment was done that showed no visible injuries to the patient. Patient states he does not remember what happened. Monitored patient in clinic for 30 minutes.
Much more pain at the injection site than the previous shot.  Responded somewhat to ibuprofen and ice.  Rubbed the site, rotated the shoulder and applied ice.  Went to bed after 11pm and woke up at midnight with a slight fever (100) and achy muscles and joints.  Could not get comfortable and got out of bed around 4am, took some tylenol/ibuprofen with limited results.  Continued with chills and joint pain even with the over the counter meds on board.
Red, hot, swollen tissue @ injection site Cellulitis Started on Keflex 500mg 1 q 12'x10 days
I had pain on the injection cite , chills for a day ,body ache for a day , and headache for 3 days.
8 hours  of severe headache 6 hours of nausea  Treated with rest and Tylenol (1000mg) after 5 hours
That evening patient experienced reddness, soreness and a hardening of the skin. Mother reported giving Ibuprofen. Patient did report to mother that his arm "hurt". Patient came in Wednesday The 4th to have arm looked at. Nurse was unavailable and secretary told mother to have MD look at it or come back on later date. Patient and mother came on Friday the 6th and Nurse measured site on Left deltoid. It was 4 1/2 inches by 3 1/4 inches, reddness noted and warm to touch. Told Mother to given Ibuprofen or Tylenol and place cold packs to site for a few minutes throughout the day. Nurse also outlined area with a marker to show if reddness was increasing or decreasing. I called Mother on 12/9/19 to follow up and she said the reddness was "gone" and her son was fine and playing.
Severe pain from her left leg, hip down to her ankle; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Severe pain from her left leg, hip down to her ankle) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Severe pain from her left leg, hip down to her ankle). At the time of the report, PAIN IN EXTREMITY (Severe pain from her left leg, hip down to her ankle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
died; A spontaneous report from was received from a Consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and mentioned that a patient who had received the Moderna vaccine had died, and so they were concerned about getting the second dose.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On unknown date, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, The patient mentioned that a patient who had received the Moderna vaccine had died, and so they were concerned about getting the second dose.  Laboratory details are not provided.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events was considered Fatal.; Reporter's Comments: This is a case of death of an unknown age female subject with unknown medical history, who died on an unknown day after receiving first dose of vaccine. Very limited information has been provided at this time.  No follow up is possible.; Reported Cause(s) of Death: Unknown cause of death
shots didn't work/ Suspected vaccination failure; shots didn't work; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 19-Oct-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The reporter reported that it was good for other, but the patient shots did not work. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact detail were available.
Injection site pain; injection site erythema; injection site induration Information has been received from a registered nurse (RN) concerning a female who on 14-OCT-2005 was vaccinated with IM with a dose of pneumococcal 23v polysaccharide vaccine (lot #650087/0815P). The RN reported that on 14-OCT-2005 the patient developed injection site pain/throbbing, redness and hardness. Unspecified medical attention was sought. Subsequently the patient recovered from the injection site pain/throbbing, redness and hardness. The reported requested a lot check. The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 62-year-old male patient who received SHINGRIX (batch number L7F7E, expiry date June 2019) for prophylaxis. Concurrent medical conditions included blood pressure high. Concomitant products included amlodipine, Clobetasol Ointment and PROCTOSOL-HC. On 21st June 2018 17:30, the patient received the 1st dose of SHINGRIX (intramuscular). In June 2018, less than a week after receiving SHINGRIX, the patient experienced injection site pain, injection site swelling and injection site erythema. In June 2018, the outcome of the injection site pain, injection site swelling and injection site erythema were recovered/resolved. The reporter considered the injection site pain, injection site swelling and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the right arm. After receiving SHINGRIX, the patient experienced pain, redness, soreness, and swelling at the injection site. The pain lasted for about 2 days, the redness lasted for about 4 days along with the soreness and swelling lasted for total of 3 days. The redness was circular and 4 inches in diameter. The patient was now recovered. The reporter gave permission to contact his health care physician.
Painful joints in shoulders,  and knees muscle pain in back, headache, starting the night of the injection
Arm became sore several hours after vaccination.  Continued to worsen, within 6-7 hours suffered severe pain and complete inability to move arm.  Pain radiated into neck, shoulder and back.  It is now 4 days following injection.  Pain has subsided only when arm is not moved, arm only slightly mobile, can raise arm very little and even that still causes considerable pain.  Cannot lift any weight with left hand.  I would have returned to doctor's office but it is a holiday weekend.  Have tried Aleve, ice packs, heating pad with little relief.
Armpit lymph node swelling and tender after vaccine. Submandibular and neck lymph node also swollen on left side, persisting for several days.
9/16/21 (9 days after 2nd vaccination) Chest Pain started while I was driving my children to school, I arrived at work not feeling well with continued chest pain. I had one of my co-workers check my BP and pulse, I was pale and sweaty. I checked in as a patient and saw an NP. They performed an EKG and ran some labs all of which are available in a database. NP referred me to PCP. I was able to a PCP appointment on the same day. I was referred to same day cardiology. I saw a specialist also on 9/16/21. I had another EKG, echo, and a treadmill stress test, and was sent home to await results. I was notified the next day that I had a small pericardial effusion, Specialist wanted me to have a repeat echo in 2 weeks and said he would call me with the results. I went for the repeat echo on 9/30/21, after the echo was complete the tech asked if I was scheduled to see the doctor that day, I told her No. She wanted to call up to the office before I left to make sure he didn?t want to see me. It was decided that I should see the doctor, so I saw specialist again. He said the pericardial effusion was still there no worse but no better. Will at the visit I reported some of the symptoms I had been feeling during the time between the 2 visits (cool tingling sensation on the left side of my chest up to my left clavicle, continued feeling of pressure, and an episode of tachycardia that occurred while I was at work on 9/24/21 were my heart rate was 120-130. He decided to order a 3-day Holter and start me on anti-inflammatory medication (Colchicine and Ibuprofen). Specialist wanted to see me again in 2 weeks for another echo and appointment. I began wearing the Holter that afternoon 9/30/21- 10/3/21. The monitor was dropped off on 10/4/21. I received the Holter report on Monday 10/11/21 around 7:00pm) It did show brief episodes of Wenckebach. I sent specialist because he did not call to discuss these results like he had before. One of his mid-levels called me back and stated that I shouldn?t be concerned. I explained to him that I am still having episodes of palpitations and intermittent chest discomfort, I inquired about the brief episodes of Wenckebach. He told me that I should be able to feel that and Wenckebach wouldn?t be that cause of palpitations. He told me to keep taking the anti-inflammatory medication and to keep the scheduled follow up appointment with specialist  on 10/21/21 for a repeat echo and visit.   1st vaccine was received on 8/3/21 Covid symptoms started on 8/12/21 (I was tested on 8/12/21. I was in quarantine for 10 days, and returned to work on 8/23/21) 2nd Vaccine was received on 9/7/21
Bivalent Moderna vaccine was administered by mistake as a primary series dose; No Adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Bivalent Moderna vaccine was administered by mistake as a primary series dose) and NO ADVERSE EVENT (No Adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    In November 2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Bivalent Moderna vaccine was administered by mistake as a primary series dose) and NO ADVERSE EVENT (No Adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Bivalent Moderna vaccine was administered by mistake as a primary series dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Bivalent Moderna vaccine was administered by mistake as a primary series dose).    No relevant concomitant medications were reported.  No treatment information was provided.
Rash that began Saturday afternoon on Head and neck, moeved down to arms by 5 pm, moved to legs overnight. Beneyrl and bendryl creme applied at 5 pm when noticing rash on arms. All still present, some less noticeable now
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 77-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included ZOSTAVAX (received in November 2018). On 21st February 2019, the patient received the 2nd dose of SHINGRIX (intramuscular). On 21st February 2019, immediately after receiving SHINGRIX, the patient experienced injection site pain. On 23rd February 2019, the patient experienced itchy rash and red rash. On an unknown date, the patient experienced pain in arm, erythema of extremities, extremities hot feeling of and painful rash. On an unknown date, the outcome of the injection site pain, erythema of extremities, red rash and extremities hot feeling of were unknown and the outcome of the pain in arm and painful rash were recovered/resolved and the outcome of the itchy rash was recovering/resolving. It was unknown if the reporter considered the injection site pain, pain in arm, erythema of extremities, itchy rash, red rash, extremities hot feeling of and painful rash to be related to SHINGRIX. Additional details were provided as follows: The patient received 2nd dose of SHINGRIX vaccine on left arm. At the time of vaccine administration the injection hurt, the patient's arm was sore and became hot and red. 2 days after vaccination, the patient started to develop red bumps which could not be felt. The bumps broke on her thighs, on the inside of her legs, behind her knee caps and back. The rash was itchy. The patient went to a clinic on 25th February 2019 and was provided creams. The patient went to her primary care physician on 27th February 2019 because she felt like she was not getting better. The patient noted that she red bumps broke out in places on her buttock and inside of left arm that were the size of a pencil eraser and solid red.
The patient received his primary series of Pfizer covid-19 vaccines on 04/01/2021 and 04/22/2021. He denied receiving any Covid-19 vaccine prior to the date of immunization on 9/26/2021. He received his booster dose less than six months after he received his primary series.
Severe nausea so much that I have not been able to keep anything down since about 3 hours after the shot.
Began on 1/13/03 PM with lesions on trunk and scalp; lip erythema with central vesicles, about 15  lesions. Afebrile.
Anaphylaxis post flu vaccine 10/15/03. The medical record received on 2/17/04 states anxiety, increased pulse, wheezing, and erythema. Medical record states vomiting, allergic reaction. msv
Vaccination administered to patient at 17 years of age. Indication is for 18 years and older. Patient was followed up with, and stated no adverse reaction. Patient states mother signed her up for vaccine.
The  next morning after the injection I had chills and nausea. A few hours later those symptoms got worse with added dizziness and tired feeling plus a headache. That evening I had an extreme headache, muscle and joint pain, 101.7 fever, dizziness, stuffy nose, sore throat, painful lymph nodes and burning/pain in my lungs. When my fever broke I had extreme sweating. For the next 5 days I had various symptoms of lymph node pain/swelling, muscle pain and weakness, joint pain, higher than normal temperatures (approximately 99 degrees), severe headaches that wouldn't go away with Tylenol or Ibuprophen, mental fog, sore throat, stuffy nose, slight cough, diarhea, nausea, sensitivity to heat, lethargy. I am currently still unable to breathe through my right nostril, have a slight cough and headache.
Patient stated she has an itchy and dry scalp and is now losing her hair. She's also losing her voice. Her PCP referred her to a dermatologist but she has not yet been seen.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. The patient's medical history was not reported. On 12-FEB-2015 the patient was received improperly stored VARIVAX (lot # K007979, expiration date 03-JUN-2016, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
This spontaneous report was received from a registered nurse concerning a female patient of unknown age. The medical history of the patient included a case of shingles before the vaccination at an unspecified time. On an unknown date in 2009, the patient was vaccinated with ZOSTAVAX (lot number, expiry date, dose and route unspecified). No concomitant therapy was reported. Approximately on an unknown date in September 2013 (reported as this past week), the patient was diagnosed with shingles. She sought medical attention (the patient informed the nurse by phone on 02-OCT-2013). No treatment was given and no lab te4sts were performed. The outcome of shingles was reported as not resolved. The relatedness for shingles was unknown for ZOSTAVAX. Additional information has been requested.
On Friday, Oct 14 2005 employee contacted employee health nurse and related on 10/12/2005 she had discomfort, swelling and redness at injection site which she reported has continued. Advised to be evaluated in on site ER. 10/14/2005 Diagnosis is cellulitis of vaccine injection site. RX Keflex 500 mg QID 28, Ibuprofen for pain, swelling, warm moist packs to site. Employee was afebrile and denied body aches. Monday 10/17/2005 F/U in Employee Health physicians office, C/O throbbing at injection site, chilling, aching and nauseated. Afebrile. Continued Keflex and ibuprofen. Rx for Benadryl 25mg PO Q 6 hours as needed for itching at injection site.
Receiving dose from a vial that was left out open in room temperature for 24hours; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Receiving dose from a vial that was left out open in room temperature for 24hours) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067h21a) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2022 at 9:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2022 at 9:00 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Receiving dose from a vial that was left out open in room temperature for 24hours). On 07-Jan-2022 at 9:00 AM, EXPIRED PRODUCT ADMINISTERED (Receiving dose from a vial that was left out open in room temperature for 24hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment medications were reported. Date the vial was initially stored in the refrigerator was on 05 Jan 2022 at 5 PM, first punctured on 06 Jan 2022 at  8 AM.
pt recv vax & exp hypoesthesia (C2 to C6) & weakness of the upper arm;pt past medical history includes angioimmunoplastic lymphadenopathy (immunosupressed);
Child received multiple injections on 2/7/00. Mom reports child had a seizure on 2/14/00 which required ER visit. On 2/13/00, child had fever of 103.5, diarrhea and vomiting. Mom gave Tylenol and Motrin, alternately. Diarrhea persisted through 2/15/00. Fever and vomiting lasted through 2/14/00.
The next day after vaccine, I experienced all symptoms of COVID 19 except for sore throat. I went in to see my family practice doctor, got tested for COVID 19. It came back negative. These symptoms lasted for a month. I thought I was going to die. I still have fatigue, wheezing and a cough. I have been shaky and have fallen several times. I have lost 40 pounds since I received this vaccine. My family practice sent me to a GI doctor. I have also been referred to an oncologist and cardiologist to do CT scan and figure out why I still experience fatigue. Cardiologist appt on 07/13/2021.
Slight fever, chills, aches in muscles and bones 9 hours after 2nd dose